Autorizzo l’utilizzo di cookies.

Accetto Utilizziamo cookies per migliorare il nostro servizio e realizzare statistiche. Questa funzione puó essere disattivata cambiando la configurazione del browser. Continuando a navigare senza modificare questi parametri, consideriamo che l’uso di cookies sia accettato

Cerca risultati

I risultati della tua ricerca per {cas}

Filtro gerarchia

  • Castanospermine, 99%

    CAS: 79831-76-8

    [79831-76-8], C8H15NO4, F.W. 189.21, Solid, m.p. 213-217°, BRN 3588654, MDL MFCD00017555, TSCA No

    Codici di rischio: H302-H312-H332

    Codici precauzionali (UE) P261-P264b-P270-P271-P280-P302+P352-P304+P340-P312-P330-P363-P403-P501c

    Saul et al. Studies on the mechanism of castanospermine inhibition of α- and β-glucosidases. Arch.Biochem.Biophys. 1984, 230,(2), 668-75.

    Gruters et al. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature. 1987, 330,(6143), 74-7.

    Struttura
  • Casein Peptone

    CAS: 91079-40-2

    [91079-40-2], EINECS 293-428-4, MDL MFCD00131829, TSCA No

    Frohnert, A.; Kreißel, K.; Lipp, P.; Dizer, H.; Hambsch, B.; Szewzyk, R.; Selinka, H. C. Removal of Surrogate Bacteriophages and Enteric Viruses from Seeded Environmental Waters Using a Semi-technical Ultrafiltration Unit. Food. Enviorn. Virol. 2015, 7 (2), 173-182.

    Baltierra-Trejo, E.; Sánchez-Yáñez, J. M.; Buenrostro-Delgado, O.; Márquez-Benavides, L. Production of short-chain fatty acids from the biodegradation of wheat straw lignin by Aspergillus fumigatus. Bioresour. Technol. 2015, 196, 418-425.

    Struttura
  • Caspase-1 Inhibitor II

    CAS: 178603-78-6

    [178603-78-6], C24H33ClN4O8, F.W. 540.99, Powder, RTECS AY3079566, MDL MFCD00237124, TSCA No

    Struttura
  • Caspase-3/7 Inhibitor

    C14H16N2O5S, F.W. 324.35, Powder, MDL MFCD22581511, TSCA No

    Struttura
  • Casein, Hammarsten Grade

    CAS: 9000-71-9

    [9000-71-9], Powder, EINECS 232-555-1, RTECS FI3519420, MDL MFCD00081481, TSCA Yes

    A.A.Elfagm; J.V.Wheelock. Heat interaction between α-lactalbumin, β-lactoglobulin and casein in bovine milk. Journal of Dairy Science. 1978, 61,(2), 159-163.

     

    B.Tarodo De La Fuente. Solvation of casein in bovine milk. Journal of Dairy Science. 1975, 58,(3), 293-300.

    Struttura
  • Caspase-3 Substrate V, fluorogenic

    C60H75N14O21S, F.W. 1360.38, Lyophilized powder, MDL MFCD25541471, TSCA No

    Struttura
  • Caspase-2 Substrate, chromogenic

    C31H43N9O14, F.W. 765.72, Lyophilized powder, MDL MFCD07780993, TSCA No

    Struttura
  • Casein blocking buffer, 3% in TBS

    Liquid, MDL MFCD01634587, TSCA Yes

    R.A.Wirtz; F.Zavala; Y.Charoenvit; G.H.Campbell; T.R.Burkot; I.Schneider; K.M.Esser; R.L.Beaudoin; R.G.Andre. Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ. 1987, 65,(1), 39-45.

     

    Georg Widera; Melissa Austin; Dietmar Rabussay; Cheryl Goldbeck; Susan W.Barnett; Minchao Chen; Louisa Leung; Gillis R.Otten; Kent Thudium; Mark J.Selby; Jeffrey B.Ulmer. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. The Journal of Immunology. 2000, 164,(9), 4635-4640.

    Struttura
  • Casein, tech.

    CAS: 9000-71-9

    [9000-71-9], m.p. ca 280° dec., EINECS 232-555-1, RTECS FI3519500, MDL MFCD00081481, TSCA Yes

    Irshad, I.; Kanekanian, A.; Peters, A.; Masud, T. Antioxidant activity of bioactive peptides derived from bovine casein hydrolysate fractions. J. Food Sci. Technol. 2015, 52 (1), 231-239.

    Sharma, A. K.; Sawhney, I. K. Modelling moisture sorption characteristics in dried acid casein using connectionist paradigm vis-à-vis classical methods. J. Food Sci. Technol. 2015, 52 (1), 151-160.

    Struttura
  • Castor oil

    CAS: 8001-79-4

    [8001-79-4], b.p. 313°, f.p. 230°(446°F), d. 0.961, n20/D 1.4780, EINECS 232-293-8, RTECS FI4100000, MDL MFCD00130746, TSCA Yes

    Gurunathan, T.; Mohanty, S.; Nayak, S. K. Isocyanate terminated castor oil-based polyurethane prepolymer: Synthesis and characterization. Prog. Org. Coat. 2015, 80, 39-48.

    Saez-Bastante, J.; Pinzi, S.; Jimenez-Romero, F. J.; de Castro, M. D. L.; Priego-Capote, F.; Dorado, M. P. Synthesis of biodiesel from castor oil: Silent versus sonicated methylation and energy studies. Energy Convers. Manage. 2015, 96, 561-567.

    Struttura
  • Caspase-1 Inhibitor I

    CAS: 143313-51-3

    [143313-51-3], C23H32N4O8, F.W. 492.52, Powder, MDL MFCD00237123, TSCA No

    Struttura
  • Casein blocking buffer, 3% in PBS

    Viscous liquid, MDL MFCD01634587, TSCA Yes

    Udai Banerji; Anne O'Donnell; Michelle Scurr; Simon Pacey; Sarah Stapleton; Yasmin Asad; Laura Simmons; Alison Maloney; Florence Raynaud; Maeli Campbell; Michael Walton; Sunil Lakhani; Stanley Kaye; Paul Workman and Ian Judson. Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies. Journal Of clinical Oncology. 2005, 23 (18), 4152-4161.

    Greg Welder; Issam Zineh; Michael A. Pacanowski; Jason S. Troutt; Guoqing Cao and Robert J. Konrad. High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol. The Journal of Lipid Research. 2010, 51, 2714-2721.

    Struttura
  • Caspase-3 Inhibitor III

    CAS: 285570-60-7

    [285570-60-7], C21H31ClN4O11, F.W. 550.94, Powder, MDL MFCD01323001, TSCA No

    Struttura
  • Caspase-3 Substrate III, fluorogenic

    CAS: 189696-20-6

    [189696-20-6], C50H62N10O22, F.W. 1155.08, Lyophilized powder, MDL MFCD00798785, TSCA No

    Struttura
  • Casein blocking buffer, 3% in PBS, with 0.02% sodium azide

    Liquid, MDL MFCD01634587, TSCA Yes

    Struttura
  • Caspase-1 Inhibitor IV

    CAS: 154674-81-4

    [154674-81-4], C33H42N4O10, F.W. 654.71, Powder, MDL MFCD00798794, TSCA No

    Struttura
  • Casein hydrolysate, enzymatic digest, Ultrapure, Thermo Scientific

    CAS: 65072-00-6

    [65072-00-6], Powder, EINECS 265-363-1, MDL MFCD00282824, TSCA Yes

    Struttura
  • Caspase-9 Inhibitor III

    CAS: 403848-57-7

    [403848-57-7], C24H35ClN6O9, F.W. 587.02, Powder, MDL MFCD02259690, TSCA No

    Struttura
  • Caspase-7 Substrate I, fluorogenic

    C60H74N14O21, F.W. 1327.31, Lyophilized powder, MDL MFCD25372010, TSCA No

    Struttura
  • Casein Kinase II Substrate

    C52H87N19O24, F.W. 1362.38, Solid, MDL MFCD00080103, TSCA No

    Struttura
  • Casein, high nitrogen, 95%

    CAS: 9000-71-9

    [9000-71-9], Powder, m.p. ca 280° dec., EINECS 232-555-1, RTECS FI3519420, MDL MFCD00081481, TSCA Yes

    Struttura
  • Casein sodium salt

    CAS: 9005-46-3

    [9005-46-3], Powder, RTECS FI3540000, MDL MFCD00130736, TSCA Yes

    François Chevalier; Alan L Kelly. Proteomic quantification of disulfide-linked polymers in raw and heated bovine milk. Journal of Agricultural and Food Chemistry. 2010, 58, (12), 7437-7444.

    K L Houseknecht; D E Bauman; D G Fox; D F Smith. Abomasal infusion of casein enhances nitrogen retention in somatotropin-treated steers. Journal of Nutrition. 1992, 122, (8), 1717-1725.

    Struttura
  • Caspase-8 Inhibitor I, cell permeable

    C95H162N20O26, F.W. 2000.41, Lyophilized powder, MDL MFCD25372008, TSCA No

    Struttura
  • Caspase-3 Inhibitor I, cell permeable

    C94H158N20O27, F.W. 2000.37, Lyophilized powder, MDL MFCD08703605, TSCA No

    Struttura
  • Casein, Hammarsten, Ultrapure, Thermo Scientific

    CAS: 9000-71-9

    [9000-71-9], Lyophilized powder, m.p. ca 280° dec., EINECS 232-555-1, RTECS FI3519420, MDL MFCD00081481, TSCA Yes

    Hammerstein, O. Textbook of physiological chemistry, 7th ed; J. Wiley: New York, 1915; p. 652.

    Struttura
  • Casein, high nitrogen, Ultrapure, Thermo Scientific

    CAS: 9000-71-9

    [9000-71-9], Powder, m.p. ca 280° dec., EINECS 232-555-1, RTECS FI3519420, MDL MFCD00081481, TSCA Yes

    Struttura
  • Casein blocking buffer, 3% in TBS, with 0.02% sodium azide

    Liquid, MDL MFCD01634587, TSCA Yes

    Struttura
  • beta-Casomorphin (1-5), bovine

    CAS: 72122-63-5

    [72122-63-5], C30H37N5O7, F.W. 579.64, Solid, MDL MFCD00076332, TSCA No

    Struttura
  • beta-Casomorphin (1-5), amide, bovine

    CAS: 83936-21-4

    [83936-21-4], C30H38N6O6, F.W. 578.66, Solid, MDL MFCD00076333, TSCA No

    Struttura
  • beta-Casomorphin (1-4), amide, bovine

    CAS: 74135-04-9

    [74135-04-9], C28H35N5O5, F.W. 521.61, Solid, MDL MFCD00076328, TSCA No

    Struttura
  • alpha-Casein (90-95)

    CAS: 83471-50-5

    [83471-50-5], C38H57N9O9, F.W. 783.93, Solid, MDL MFCD00076691, TSCA No

    Struttura
  • beta-Casomorphin (1-3)

    CAS: 72122-59-9

    [72122-59-9], C23H27N3O5, F.W. 425.48, Solid, MDL MFCD00038820, TSCA No

    Struttura
  • beta-Casomorphin (1-4), bovine

    CAS: 74171-19-0

    [74171-19-0], C28H34N4O6, F.W. 522.59, Solid, MDL MFCD00076327, TSCA No

    Struttura
  • beta-Casomorphin (1-6), bovine

    CAS: 77434-43-6

    [77434-43-6], C35H44N6O8, F.W. 676.76, Lyophilized powder, MDL MFCD00076343, TSCA No

    Struttura
  • beta-Casomorphin, human, 95+%

    CAS: 102029-74-3

    [102029-74-3], C44H61N7O11, F.W. 864.01, Powder, MDL MFCD00076324, TSCA No

    Struttura
  • beta-Casomorphin (1-3), amide

    C23H28N4O4, F.W. 424.49, Solid, MDL MFCD00076325, TSCA No

    Struttura
  • alpha-Casein, Certified Mass Spec Grade

    CAS: 9000-71-9

    [9000-71-9], F.W. 23,616 Da, Lyophilized powder, m.p. 280°, EINECS 232-555-1, MDL MFCD00130477, TSCA Yes

    Struttura
  • 8-Carboxynaphthalene-1-carboxamide, tech. 85%

    CAS: 5811-88-1

    [5811-88-1], C12H9NO3, F.W. 215.21, m.p. 265-270°, BRN 2213597, MDL MFCD00052020, TSCA No

    Codici di rischio: H315-H319-H335

    Codici precauzionali (UE) P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501c

    Struttura
  • Calcium D-gluconate monohydrate, 98+%

    CAS: 66905-23-5

    [66905-23-5], C12H22CaO14•H2O, F.W. 448.40 (430.37anhy), m.p. ca 195° dec., EINECS 206-075-8, RTECS EW2100000, MDL MFCD00064209, TSCA Yes

    Panagiotopoulos,N.C.; Jeffrey, G.A.; La Placa, S.J.; Hamilton, W.C. The crystal structures of the A and B forms of potassium D-gluconate monohydrate by neutron diffraction. Acta Cryst. 1974, 30, 1421-1430.

    Martina Vavrusova.; Merete Bogelund Munk.; Leif H. Skibsted. Aqueous Solubility of Calcium l-Lactate, Calcium d-Gluconate, and Calcium d-Lactobionate: Importance of Complex Formation for Solubility Increase by Hydroxycarboxylate Mixture. J. Agric. Food Chem. 2013, 61, (34), 8207-8214.

    Struttura
  • Calcium glycerophosphate hydrate, 97%

    CAS: 28917-82-0

    [28917-82-0], C3H7CaO6P•xH2O, F.W. 210.15(anhy), EINECS 249-312-0, MDL MFCD00151656, TSCA No

    Struttura
  • (1R)-(-)-Camphorquinone, 98%

    CAS: 10334-26-6

    [10334-26-6], C10H14O2, F.W. 166.22, m.p. 197-202°, BRN 2327696, MDL MFCD00082863, TSCA No

    For use in the kinetic resolution of 1,2-diols by means of diastereomeric acetal formation, see: J. Chem. Soc., Chem. Commun., 1600 (1984).

    /n

    Struttura
  • Calcium 2,4-pentanedionate hydrate, 99%

    CAS: 345909-31-1

    [345909-31-1], C10H14CaO4•xH2O, F.W. 238.30(anhy), Crystalline, m.p. 175° dec., EINECS 243-001-3, MDL MFCD00013486, TSCA Yes

    Struttura

Prodotti chimici

Scienze della vita

Metalli e materiali

Catalizzatori

Apparecchiature di analisi e di laboratorio